|
Effects of different blood purification modalities on prognosis of renal damage induced by arsine poisoning
2018, 17 (09):
583-587.
doi: 10.3969/j.issn.1671-4091.2018.09.002
【Abstract】Objective To investigate the effects of continuous venous-venous hemofiltration (CVVH) and hemodialysis (HD) combined with hemoperfusion (HP) on the prognosis of renal injury in patients with arsine poisoning. Methods A total of 40 patients with arsine poisoning treated in the hospital were divided into two groups: control group treated with HD+HP and observation group treated with CVVH+HP in addition to routine management. The duration of clinical symptoms, blood purification and hospitalization were record. The changes of hemolysis and renal function indices, and the arsine content in dialysate and urine at the time of admission and after the treatment were compared between the two groups. Results The average duration of blood purification (t=13.836, P=0.003), hemoglobinuria (t=7.381, P=0.041), fever and chills (t=9.029, P=0.034), jaundice (t=7.903, P=0.039), fatigue, back pain and other clinical symptoms (t=9.623, P=0.022) and hospitalization (t=18.349, P=0.001) were significantly shortened in observation group as compared with those in control group. Serum Hb content decreased after the treatment for one day, and began to rise after the treatment for 3 days. Serum total bilirubin (TBIL) decreased continuously after the treatment. Serum creatinine (Scr) and BUN increased at the first treatment day and then decreased continuously. Analysis of variance showed that the values of serum HB, TBIL, Scr and BUN at the admission were significantly different from those at the 4 time points after the treatment (F=18.591, P=0.006 for serum HB; F=71.855, P<0.001 for serum TBIL; F=154.622, P<0.001 for Scr; F=17.728, P=0.011 for BUN). At the 4 time points after the treatment, the values of serum TBIL, serum HB, Scr and BUN in both control group and observation group were significantly different as compared with those at the admission (for serum TBIL: t=7.664, 6.722, 6.330 and 12.684, P= 0.017, 0.021, 0.024 and 0.006 in control group; t=8.338, 12.564, 14.629 and 7.188, P=0.014, 0.006, 0.005 and 0.019 in observation group; for serum Hb: t=4.382, 4.168, 4.496 and -4.779, P=0.048, 0.044, 0.047 and 0.041
in control group; t=6.416, 4.512, 4.408 and 5.081, P=0.023, 0.046, 0.049 and 0.041 in observation group; for Scr: t=- 11.680, - 12.665, - 5.768 and - 9.846, P=0.007, 0.006, 0.033 and 0.010 in control group; t=- 8.526, -12.814, - 10.596 and 17.928, P=0.013, 0.006, 0.009 and 0.003 in observation group; for BUN: t=- 4.575, -4.509, 4.826 and 6.646, P=0.045, 0.046, 0.04 and 0.031 in control group; t=-4.552, 5.778, 6.269 and 6.744, P=0.046, 0.043, 0.040 and 0.032 in observation group). Furthermore, the values of serum TBIL, serum HB, Scr and BUN at the 4 time points were clinically better in observation group than in control group (for TBIL: t=10.757, 19.228, 3.869 and 6.509, P=0.009, 0.003, 0.023 and 0.018; for serum HB: t=4.375, 3.828, 6.032 and 5.966, P=0.043, 0.048, 0.037 and 0.038; for Scr: t=4.792, 7.105, 5.811 and 6.225, P=0.041, 0.033, 0.037 and 0.035; for BUN: t=4.492, 6.113, 5.708 and 7.116, P=0.048, 0.041, 0.043 and 0.039). After the treatment for 7 days, arsine content in dialysate and urine decreased to normal levels, and were lower in observation group than in control group (arsine in dialysate: F=12.234, P=0.005; arsine in urine: F=10.856, P=0.011). Conclusion The early use of CVVH+HP for blood purification in arsine poisoning patients can quickly remove arsine and its related compounds, shorten the disease course, relieve kidney damage, and improve prognosis of the patients.
Metrics
|